IM Cannabis Corp.

CNSX: IMCC


Canadian symbol: IMCC.CN
US symbol: IMCNF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5185.09M
Enterprise Value 3176.71M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)21.88
Price/Book (mrq)7.06
Enterprise Value/Revenue 320.89
Enterprise Value/EBITDA 6-54.96

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 312,700.00%
S&P500 52-Week Change 35.66%
52 Week High 31.3400
52 Week Low 30.0100
50-Day Moving Average 30.9865
200-Day Moving Average 30.5371

Share Statistics

Avg Vol (3 month) 3348.69k
Avg Vol (10 day) 3142.15k
Shares Outstanding 5145.74M
Float 72.6M
% Held by Insiders 150.08%
% Held by Institutions 14.51%
Shares Short (Jun. 14, 2020) 4169.06k
Short Ratio (Jun. 14, 2020) 40.39
Short % of Float (Jun. 14, 2020) 4N/A
Short % of Shares Outstanding (Jun. 14, 2020) 40.12%
Shares Short (prior month May 14, 2020) 4574.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin -11.61%
Operating Margin (ttm)-43.40%

Management Effectiveness

Return on Assets (ttm)-8.81%
Return on Equity (ttm)-3.67%

Income Statement

Revenue (ttm)8.46M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-31.50%
Gross Profit (ttm)3.93M
EBITDA -3.21M
Net Income Avi to Common (ttm)-982k
Diluted EPS (ttm)-0.0090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.7M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)3.99
Current Ratio (mrq)9.08
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-7.29M
Levered Free Cash Flow (ttm)-7.36M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
IMCC.CN
IM Cannabis
2 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
1 month ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
50.08%% of Shares Held by All Insider
4.51%% of Shares Held by Institutions
9.04%% of Float Held by Institutions
1Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by IM Cannabis Corp.


IMC Reports Exercise of Warrants and Options

IMC Reports Exercise of Warrants and Options

Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives * Currency is in CAD$ unless specified otherwise TORONTO and GLIL YAM, Israel, June 30, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, annou... Read More...
IMC Announces Focus Medical's First Import from Canada to Israel, Strengthening International Network

IMC Announces Focus Medical’s First Import from Canada to Israel, Strengthening International Network

Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a global medical cannabis brand Focus Medical has successfully imported approximately 200kg of medical cannabis from Canada, now seven suppliers cultivating under IMC brand across Israel, Spain and Canada IMC brand well positioned for Isra... Read More...
The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

The Bee Must Go On: Kaplan and Hexco Team Up to Hold Live, Online National Spelling Bee During Week of July 26

Kaplan Inc., a premier provider of educational programs and services, has teamed up with Hexco, Inc., DBA Hexco Academic, to co-host a national online spelling bee during the week of July 26, 2020. The bee will provide an opportunity for the nation’s top spellers to compete online, giving priority to eighth-grade students who were schedul... Read More...
IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

New generation of evidence-based cannabis products to be launched in IsraelIMC to be exclusive distributor of CannEpil® in Israel for five-year termCannEpil® was developed by MGC Pharma for the treatment of refractory epilepsy* Currency is in CAD$ unless specified otherwiseTORONTO and GLIL YAM, Israel , June 15, 2020 - IM Cannabis Corp. (... Read More...
IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A

TORONTO and GLIL YAM, Israel, May 27, 2020  /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) announces that filing of the Company's interim financial statements for the three month period ended March 31, 2020 (the "Q1 Financial Statements") and associated management's discussion and analysis (the "Q1 MD&A", and collective... Read More...
IMC Announces Focus Medical's Successful Import of Medical Cannabis from Spain to Israel

IMC Announces Focus Medical’s Successful Import of Medical Cannabis from Spain to Israel

Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The medical cannabis was supplied by Linneo Health, the Company's strategic supply partner in Spain and an EU-GMP global supplier of medicinal cannabis Six suppliers now cultivating medical cannabis to Focus Medical for sale under the... Read More...
IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

Executing on long-term strategy to build distribution platform across the large German market Sales commitment for 465kg of IMC-branded medical cannabis over the next twelve months Together with other announced binding purchase agreements in Germany, a total of 825kg of IMC-branded medical cannabis is committed for sale over the next tw... Read More...
IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg of medical cannabis between 2020 and 2023 Focus Medical has now secured all the supply required under the six binding pharmacy sales agreements it has signed In 2020, Focus Medical signed binding sales agreements for pharmacies to purchase 33,075kg in medi... Read More...
IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

* Currency is in CAD$ unless specified otherwise PharmYarok entered into a three-year binding sales agreement with Focus Medical for 12,600kg of medical cannabis under the IMC brand PharmYarok to distribute IMC-branded product through its retail pharmacy and its leading e-commerce platform Binding sales agreements signed by Focus Medi... Read More...
IMC Announces Two Additional Binding Sales Agreements by Focus Medical - Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period

IMC Announces Two Additional Binding Sales Agreements by Focus Medical – Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period

Focus Medical has entered into two additional binding sales agreements: Max Pharm for up to 1,500kg over three years and Panaxia for 1,000kg of medical cannabis under the IMC brandMax Pharm adds IMC-branded products to its retail pharmacy and home delivery platform, and Panaxia will launch IMC products across the largest home delivery pla... Read More...
IMC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel's Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

IMC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel’s Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel's largest pharmacy chain, for 13,575kg of IMC branded medical cannabis productsSales to begin in April 2020 through Super-Pharm's omnichannel distribution network including 41 pharmacies licensed to sell medical cannabis, as well as home delivery ... Read More...
IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg

IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg

Focus Medical, entered into a two-year binding agreement to sell 1,000kg of medical cannabis a year to Shor Tabachnik pharmacies The two-year contract is valued at approximately CAD$12 million ; now 4,400kg for an approximate value of CAD$27 million contracted over next three years All medical cannabis sold according to this agreement wil... Read More...
IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand

IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand

IMC continues to build asset-light business model to satisfy rising demand for medical cannabis in Israel with supply of approximately 2,600kg of medical cannabis per year using Focus Medical's proprietary genetics All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 31, ... Read More...
IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna

IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna

Intelicanna , an Israeli cannabis company traded on the Tel Aviv Stock Exchange under the ticker symbol "INTL", to supply a minimum of 500kg and up to 1,000kg of medical cannabis to Focus Medical using Focus Medical's proprietary geneticsAll medical cannabis sold according to this agreement will be under the IMC brandTORONTO and GLIL YAM... Read More...
Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom

Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom

TORONTO and GLIL YAM, Israel, Jan. 30, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is preparing for the expansion of medical cannabis export from Israel in light of the recent news about government approval and the comp... Read More...
IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IMC to become 25% Joint Venture partner for cultivation and processing operation in Greece Preferred supply agreement to diversify sources of EU-GMP medical cannabis for export to Germany and other emerging markets TORONTO and GLIL YAM, Israel, Jan. 28, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world'... Read More...
IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research

IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research

TORONTO and GLIL YAM, Israel , Jan. 7, 2020 - IM Cannabis Corp. (the "Company" or "IMC") (IMCC.CN), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe , is pleased to announce that it has invested in a unique biosynthesis technology by entering into a share purchase ... Read More...
IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019

IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019

IMC currently operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. Focus Medical Herbs Ltd. ("Focus"), a licensed medical cannabis producer in Israel with whom the Company has exclusive commercial agreements, is the first major Israeli licensed producer to utilize the... Read More...
IM Cannabis Warrants Begin Trading on CSE

IM Cannabis Warrants Begin Trading on CSE

TORONTO and GLIL YAM, Israel, Nov. 21, 2019 - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations across Europe, is pleased to announce that 9,730,258 warrants of the Company (the "Warrants") have begun trading on the Canadian Securities Exchange (the "CSE") unde... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
IMCC.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed1.27CAD-0.78%
IMCNF.PK
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.93USD0.00%

Delayed data (1h)
NameAgePositionAppointed
James T. Gillis
Chairman of the Board, President, Chief Executive Officer
--Chairman of the Board, President, Chief Executive Officer2010
Steven Michael Mintz
Chief Financial Officer
--Chief Financial Officer2018
Navjit Dhaliwal
Director
--Director2018
Timothy D. Towers
Director
--Director2017
Russell George Williams
Independent Director
--Independent Director2010


Share this page